Thanaset Senawong

9PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersForestry biomass and bioproductsCheminformatics and quantitative structure-activity relationshipsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 30, 2025
Curcumin Derivative CU4c Exhibits HDAC-Inhibitory and Anticancer Activities Against Human Lung Cancer Cells In Vitro and in Mouse Xenograft Models.

Narissara Namwan, Gulsiri Senawong, Chanokbhorn Phaosiri

|Feb 26, 2025
Synergistic Anti-Cancer Activities of Curcumin Derivative CU17 Combined with Gemcitabine Against A549 Non-Small-Cell Lung Cancer Cells.

Narissara Namwan, Gulsiri Senawong, Chanokbhorn Phaosiri

|Aug 10, 2024
Anticancer Potential of Valencia Peanut (Arachis hypogaea L.) Skin Extract against Cervical Cancer Cells In Vitro and in Nude Mouse Xenograft Models.

Jarckrit Jeeunngoi, Gulsiri Senawong, Sanun Jogloy

|Jan 05, 2024
Antiproliferative polyketides from fungus Xylaria cf. Longipes SWUF08-81 in different culture media.

Kittiwan Sresuksai, Sasiphimol Sawadsitang, Phongphan Jantaharn

|Jul 29, 2023
Tiliacora triandra Leaf Powder Ethanolic Extract in Combination with Cisplatin or Gemcitabine Synergistically Inhibits the Growth of Cholangiocarcinoma Cells In Vitro and in Nude Mouse Xenograft Models.

Arunta Samankul, Gulsiri Senawong, Suppawit Utaiwat

|Jul 09, 2022
HDAC Inhibitory and Anti-Cancer Activities of Curcumin and Curcumin Derivative CU17 against Human Lung Cancer A549 Cells.

Narissara Namwan, Gulsiri Senawong, Chanokbhorn Phaosiri

Pageof 2

Frequent Collaborators

5 joint publications

Chanokbhorn Phaosiri

4 joint publications

La-Or Somsakeesit

4 joint publications

Pakit Kumboonma

2 joint publications

Sarawut Tontapha